FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072228 [Registered on: 09/08/2024] Trial Registered Prospectively
Last Modified On: 08/06/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Single Arm Study 
Public Title of Study   To evaluate the efficacy of varuna-shigru kwatha with yavakshara prakshepa in the management of mutrashmari w.s.r. urolithiasis. 
Scientific Title of Study   An open label clinical study to evaluate the efficacy of Varuna-shigru kwatha with yavakshara prakshepa in the management of mutrashmari w.s.r urolithiasis. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sugandha Sharma 
Designation  P.G. Scholar 
Affiliation  Jammu institute of ayurveda and research,Jammu 
Address  Jammu institute of ayurveda and research Nardani raipur Jammu Jammu and kashmir India

Jammu
JAMMU & KASHMIR
181123
India 
Phone  9877828721  
Fax    
Email  sugandha27648@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arjun Gupta 
Designation  Associate Professor 
Affiliation  Jammu institute of ayurveda and research,Jammu 
Address  Jammu institute of ayurveda and research Nardani Raipur Jammu Jammu and Kashmir India

Jammu
JAMMU & KASHMIR
181123
India 
Phone  9622007600  
Fax    
Email  drarjungupta17@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Arjun Gupta 
Designation  Associate Professor 
Affiliation  Jammu institute of ayurveda and research,Jammu 
Address  Jammu institute of ayurveda and research Nardani raipur Jammu Jammu and kashmir India


JAMMU & KASHMIR
181123
India 
Phone  9622007600  
Fax    
Email  drarjungupta17@gmail.com  
 
Source of Monetary or Material Support  
Jammu institute of ayurveda and research Jammu Jammu and Kashmir India 181123 
 
Primary Sponsor  
Name  Jammu institute of ayurveda and research 
Address  Jammu institute of ayurveda and research Nardani Raipur Jammu Jammu and Kashmir India 181123 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sugandha Sharma  JAMMU INSTITUTE OF AYURVEDA AND RESEARCH JAMMU   P.G. department of Shalya tantra,OPD and IPD of hospital, Nardani Raipur Jammu Jammu and Kashmir India 181123
Jammu
JAMMU & KASHMIR 
9877828721

sugandha27648@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jammu institute of ayurveda and research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N202||Calculus of kidney with calculus of ureter. Ayurveda Condition: ASMARI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Varuna shigru kwatha with yavakshara prakshepa, Reference: Yoga Ratnakara Utaradhgata Ashmari nidana chikitsa prakarana , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 01 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients with calculi measuring less than 8 mm in size.
2. Patient aged between 15-60 years.
3. Patients of either sex are taken.
4. Patients who are unwilling for surgery & those who are unfit for surgical intervention will be taken for the study.
 
 
ExclusionCriteria 
Details  1. Patient below 15 years & above 60 years.
2. Calculi measuring more than 8 mm in size.
3. Staghorn calculus.
4. Patient suffering from severe haematuria
5. Patient suffering from Pyelonephritis.
6. Patient suffering from Hydronephrosis.
7. Patient suffering from any kind of Malignancy.
8. Patient suffering from Renal Failure.
9. Participation in any other clinical trial during past 6 months.
10. Patient not willing for trial.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Patient signs and symptoms like pain, hematuria, dysuria, burning micturation, fever will get better and the size of the calculus will also get reduced.  01 month. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   06/01/2025 
Date of Study Completion (India) 31/01/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Mutrashmari (urinary stone) is one among the Ashtamahagada (eight fatal conditions) in Sushruta Samhita. It is Kapha predominance Tridoshaja Vyadhi. As per the clinical features, it is compared to urolithiasis. It is the common diseases of Murtravaha strotas. The lifetime prevalence of symptomatic urolithiasis is 10% in men and 5% in women, and the chance of the second stone formation within 7years is approximately 50% of population due to the daily lifestyle and the dietary pattern of the people.
Urolithiasis is a pathological condition of urinary system where aggregation of urinary crystalloids takes place anywhere in urinary tract i.e. from kidney to urinary bladder. When confined to kidney, it presents the feature of renal calculus. It may pass down into the ureter to become ureteric calculus and further reach the bladder to become a vesical calculus or to be held up in the urethra and become a urethral calculus.

 
Close